Continuum Advisory’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Continuum Advisory's BIIB Position: Q2 2026 in Review
Continuum Advisory opened a new position in Biogen (BIIB) in Q2 2026: 304 shares worth $65.7K. The stake represents 0.01% of the portfolio and ranks #738 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in BIIB as recently as Q3 2024.
Continuum Advisory first reported a position in BIIB in Q1 2024 and has held it in 4 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Continuum Advisory held 304 shares of Biogen worth $65.7K as of Q2 2026.
- Biogen was a new Continuum Advisory position in Q2 2026.
- Biogen made up 0.01% of Continuum Advisory's portfolio in Q2 2026, its #738 holding.
- Continuum Advisory first reported a position in Biogen in Q1 2024 and has held it in 4 quarters since.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.